NL300015I2 - 1,3-Dihydro-4-(aroyl)-2H-imidazool-2-onen en anti-hypertensief, cardiotoon en anti-trombotisch werkzaam farmaceutisch preparaat. - Google Patents

1,3-Dihydro-4-(aroyl)-2H-imidazool-2-onen en anti-hypertensief, cardiotoon en anti-trombotisch werkzaam farmaceutisch preparaat.

Info

Publication number
NL300015I2
NL300015I2 NL300015C NL300015C NL300015I2 NL 300015 I2 NL300015 I2 NL 300015I2 NL 300015 C NL300015 C NL 300015C NL 300015 C NL300015 C NL 300015C NL 300015 I2 NL300015 I2 NL 300015I2
Authority
NL
Netherlands
Prior art keywords
cardiotonic
aroyl
hypertensive
dihydro
imidazole
Prior art date
Application number
NL300015C
Other languages
English (en)
Other versions
NL300015I1 (nl
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26727558&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL300015(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of NL300015I2 publication Critical patent/NL300015I2/nl
Publication of NL300015I1 publication Critical patent/NL300015I1/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom
NL300015C 1979-06-18 2000-09-04 1,3-Dihydro-4-(aroyl)-2H-imidazool-2-onen en anti-hypertensief, cardiotoon en anti-trombotisch werkzaam farmaceutisch preparaat. NL300015I1 (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4980879A 1979-06-18 1979-06-18
US11920780A 1980-02-07 1980-02-07

Publications (2)

Publication Number Publication Date
NL300015I2 true NL300015I2 (nl) 2000-10-02
NL300015I1 NL300015I1 (nl) 2000-11-01

Family

ID=26727558

Family Applications (2)

Application Number Title Priority Date Filing Date
NL8003498A NL193752C (nl) 1979-06-18 1980-06-17 1,3-Dihydro-4-(aroyl)-2H-imidazool-2-onen en anti-hypertensief, cardiotoon en anti-trombotisch werkzaam farmaceutisch preparaat.
NL300015C NL300015I1 (nl) 1979-06-18 2000-09-04 1,3-Dihydro-4-(aroyl)-2H-imidazool-2-onen en anti-hypertensief, cardiotoon en anti-trombotisch werkzaam farmaceutisch preparaat.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NL8003498A NL193752C (nl) 1979-06-18 1980-06-17 1,3-Dihydro-4-(aroyl)-2H-imidazool-2-onen en anti-hypertensief, cardiotoon en anti-trombotisch werkzaam farmaceutisch preparaat.

Country Status (20)

Country Link
AT (1) AT375349B (nl)
AU (1) AU532783B2 (nl)
CA (1) CA1132554A (nl)
CH (1) CH646155A5 (nl)
DE (1) DE3021792A1 (nl)
DK (1) DK160269C (nl)
ES (1) ES492255A0 (nl)
FR (1) FR2459233A1 (nl)
GB (1) GB2055364B (nl)
HK (1) HK61486A (nl)
HU (1) HU186736B (nl)
IE (1) IE50646B1 (nl)
IL (1) IL60243A (nl)
IT (1) IT1143922B (nl)
MY (1) MY8600709A (nl)
NL (2) NL193752C (nl)
NO (1) NO152841C (nl)
NZ (1) NZ193935A (nl)
PH (1) PH18683A (nl)
SE (2) SE447107B (nl)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH18106A (en) * 1981-02-18 1985-03-21 Merrell Dow Pharma Novel-4-aroylimidazol-2-ones
US4405628A (en) * 1981-03-05 1983-09-20 Merrell Dow Pharmaceuticals Inc. 4-Pyridylimidazolones and method of use
US4526981A (en) * 1981-05-04 1985-07-02 Merrell Dow Pharmaceuticals Inc. [1,2-Dihydro-4(5)-acyl-2-oxo-2H-imidazol-4(5)-yl] methyl nitrates
US4371737A (en) * 1981-05-04 1983-02-01 Merrell Dow Pharmaceuticals Inc. 5-Aminomethyl-2,3-dihydro-2-oxo-1H-imidazole-4-carboxylic acid derivatives
GB2097792B (en) * 1981-05-04 1985-01-03 Merrell Dow Pharma 1,3-dihydro-2h-imidazol-2-ones
US4329470A (en) 1981-05-04 1982-05-11 Merrell Dow Pharmaceuticals Inc. 5-(4-Phenyl 1-piperidinyl)methyl-2,3-dihydro-2-oxo-1H-imidazole-4-carboxylic acid derivatives
US4329471A (en) * 1981-05-04 1982-05-11 Merrell Dow Pharmaceuticals Inc. 4-(4-Phenyl-1-piperidinyl)methyl-5-acyl-1,3-dihydro-2H-imidazol-2-ones
US4381393A (en) * 1981-05-04 1983-04-26 Merrell Dow Pharmaceuticals Inc. 4-Aminomethyl-5-acyl-1,3-dihydro-2H-imidazol-2-ones
US4367236A (en) 1981-11-04 1983-01-04 Merrell Dow Pharmaceuticals Inc. Method for the treatment of cardiac failure with alkanoylimidazol-2-one derivatives
US4410540A (en) * 1981-11-04 1983-10-18 Merrell Dow Pharmaceuticals Inc. Cardiotonic 4-aroylimidazolidin-2-ones
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
JP2007530563A (ja) * 2004-03-22 2007-11-01 ミオゲン インコーポレイティッド （ｓ）−エノキシモンスルホキシドおよびｐｄｅ−ｉｉｉ媒介疾患の治療におけるその使用
US20060030611A1 (en) * 2004-03-22 2006-02-09 Myogen, Inc. Enoximone sulfoxide enantiomers and their use in the treatment of PDE-III mediated diseases
US8067433B2 (en) 2005-11-09 2011-11-29 Zalicus Inc. Methods, compositions, and kits for the treatment of ophthalmic disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CA3089569C (en) 2007-06-04 2023-12-05 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
JP2011522828A (ja) 2008-06-04 2011-08-04 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA2828346C (en) 2011-03-01 2021-01-26 Synergy Pharmaceuticals Inc. Process of preparing guanylate cyclase c agonists
EP2804603A1 (en) 2012-01-10 2014-11-26 President and Fellows of Harvard College Beta-cell replication promoting compounds and methods of their use
US9545446B2 (en) 2013-02-25 2017-01-17 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
US9486494B2 (en) 2013-03-15 2016-11-08 Synergy Pharmaceuticals, Inc. Compositions useful for the treatment of gastrointestinal disorders
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
JP6606491B2 (ja) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼｃの超高純度アゴニスト、その作成および使用方法
KR20160042039A (ko) 2013-08-09 2016-04-18 알데릭스, 인코포레이티드 인산염 수송을 억제하기 위한 화합물 및 방법
EP3972599A1 (en) 2019-05-21 2022-03-30 Ardelyx, Inc. Combination for lowering serum phosphate in a patient
CN114539157B (zh) * 2022-03-03 2023-12-22 曲靖师范学院 一种碘促进氧化法制备4-碘代n-芳基吡唑类化合物的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2441933A (en) * 1945-07-30 1948-05-18 Hoffmann La Roche Substituted imidazolones and process of making them

Also Published As

Publication number Publication date
DE3021792A1 (de) 1981-01-22
FR2459233A1 (fr) 1981-01-09
AT375349B (de) 1984-07-25
DK160269C (da) 1991-07-22
DK259080A (da) 1980-12-19
ES8105299A1 (es) 1981-06-01
NL300015I1 (nl) 2000-11-01
GB2055364A (en) 1981-03-04
CA1132554A (en) 1982-09-28
NL193752C (nl) 2000-09-04
IE801162L (en) 1980-12-18
CH646155A5 (de) 1984-11-15
IE50646B1 (en) 1986-06-11
FR2459233B1 (nl) 1983-09-23
NL8003498A (nl) 1980-12-22
IL60243A (en) 1987-01-30
SE8501452L (sv) 1985-03-25
IT1143922B (it) 1986-10-29
NO152841C (no) 1985-11-27
NL193752B (nl) 2000-05-01
SE464559B (sv) 1991-05-13
PH18683A (en) 1985-08-29
NZ193935A (en) 1985-05-31
IL60243A0 (en) 1980-09-16
DE3021792C2 (nl) 1989-08-10
DK160269B (da) 1991-02-18
HU186736B (en) 1985-09-30
MY8600709A (en) 1986-12-31
ATA314280A (de) 1983-12-15
AU532783B2 (en) 1983-10-13
NO801796L (no) 1980-12-19
ES492255A0 (es) 1981-06-01
NO152841B (no) 1985-08-19
SE8501452D0 (sv) 1985-03-25
GB2055364B (en) 1983-06-08
AU5911880A (en) 1981-01-08
IT8048997A0 (it) 1980-06-17
SE447107B (sv) 1986-10-27
SE8004253L (sv) 1980-12-19
HK61486A (en) 1986-08-29

Similar Documents

Publication Publication Date Title
NL193752B (nl) 1,3-Dihydro-4-(aroyl)-2H-imidazool-2-onen en anti-hypertensief, cardiotoon en anti-trombotisch werkzaam farmaceutisch preparaat.
NO851881L (no) Innretning for avgivelse av flyktige, virksomme materialer.
NL193907B (nl) Basische ether en farmaceutische samenstelling die de basische ether als actief bestanddeel bevat.
IT1190824B (it) Composizione farmaceutica contenente 24,25-diidrossicolecalciferolo come ingrediente attivo
NL990010I1 (nl) Ä3HÜ-imidazo-Ä5,1-dÜ-1,2,3,5-tetrazine-4-on derivaten en farmaceutische samenstellingen, die deze derivaten bevatten.
BE848496A (fr) Derives d'amino-alcools, leur preparation et utilisation, ainsi que compositions contenant ces derives.
IT7927614A0 (it) 1,2,4,5-tetra-alchil-4-arilpiperidi ne e relative formulazioni farmaceutiche.
IT7830075A0 (it) Metiladamantil idrazine, loro preparazione e composizioni farmaceutiche che le contengono.
OA06326A (fr) Composition fongicides et leur préparation .
IT8021550A0 (it) Derivati adenosinici ad attivita'antinfiammatoria ed analgesica e composizioni terapeutiche che licontengono come principio attivo.
DE3785912D1 (de) Ungesaettigte kopolymer-zusammensetzung.
GB2048856B (en) 1,1,3,5-substituted biuret compounds and pharmaceutical composition containing the same
BE839468A (fr) Nouvelles 3-chloro-5,6-diaryl-1,2,4-triazines et leur utilisation comme agents anti-inflammatoires locaux
OA07187A (fr) Compositions pesticides, leur préparation et leur utilisation.
NL7711777A (nl) Biologisch actieve tricyclische verbindingen en farmaceutische samenstellingen, welke deze verbindingen als actief bestanddeel bevatten.
ATE1858T1 (de) 15-methanesulfonamidoprostaglandin-derivate, ihre pharmazeutischen zusammensetzungen und verfahren dafuer.
IT8023422A0 (it) 5-(4-piridinil)-2 (1h)-piridinoni, utili come agenti cardiotonici, eloro preparazione.
IL53674A (en) 3-(4-phenylpiperazinyl or 4-phenylpiperidyl) o-propyloximes,their preparation and pharmaceutical compositions comprising them
NL190120C (nl) 2,3-dihydro-4h-1-benzopyran-4-on-0-carbamoyloximen alsmede farmaceutisch preparaat daarvan.
DE3482557D1 (de) 3-methylbuten-1-polymer, dessen zusammensetzung und giessform.
DE3875835D1 (de) Antivirale, antitumoraktive und fungizide zusammensetzungen.
NL174646C (nl) 6,7-dimethoxy-4-amino-2-piperidinochinazolinen en farmaceutische preparaten die ze bevatten.
MX9203174A (es) Composicion farmaceutica con actividad antiflogistica antipirectica y antalgica.
NL7800723A (nl) Overspanningsafleider, en werkwijze voor het vervaardigen daarvan.
IT7830677A0 (it) Composizione insetticida, acaricida ed ovicida.